Packages (Simulation)
Reagent Preparation
Image (I)
Image (II)
Certificate
ELISA Kit for Pituitary Adenylate Cyclase Activating Peptide (PACAP)
ADCYAP1; PRP-48; Pituitary Adenylate Cyclase Activating Peptide
- Product No.CEB347Hu
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Sample Typeserum, plasma, tissue homogenates and other biological fluids
- Test MethodCompetitive Inhibition
- Assay Length2h
- Detection Range6.17-500pg/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 2.92pg/mL.
- DownloadInstruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
- FOB
US$ 466
For more details, please contact local distributors! US$ 665 US$ 2993 US$ 5653 US$ 46550
Specificity
This assay has high sensitivity and excellent specificity for detection of Pituitary Adenylate Cyclase Activating Peptide (PACAP).
No significant cross-reactivity or interference between Pituitary Adenylate Cyclase Activating Peptide (PACAP) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Pituitary Adenylate Cyclase Activating Peptide (PACAP) and the recovery rates were calculated by comparing the measured value to the expected amount of Pituitary Adenylate Cyclase Activating Peptide (PACAP) in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 96-104 | 101 |
EDTA plasma(n=5) | 98-105 | 102 |
heparin plasma(n=5) | 97-105 | 101 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Pituitary Adenylate Cyclase Activating Peptide (PACAP) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Pituitary Adenylate Cyclase Activating Peptide (PACAP) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Pituitary Adenylate Cyclase Activating Peptide (PACAP) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 85-99% | 96-104% | 90-103% | 93-102% |
EDTA plasma(n=5) | 91-99% | 80-91% | 83-90% | 80-103% |
heparin plasma(n=5) | 84-93% | 78-96% | 93-101% | 82-94% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
Standard | 2 | Standard Diluent | 1×20mL |
Detection Reagent A | 1×120µL | Assay Diluent A | 1×12mL |
Detection Reagent B | 1×120µL | Assay Diluent B | 1×12mL |
TMB Substrate | 1×9mL | Stop Solution | 1×6mL |
Wash Buffer (30 × concentrate) | 1×20mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 50µL standard or sample to each well.
And then add 50µL prepared Detection Reagent A immediately.
Shake and mix. Incubate 1 hour at 37°C;
3. Aspirate and wash 3 times;
4. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
5. Aspirate and wash 5 times;
6. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
7. Add 50µL Stop Solution. Read at 450 nm immediately.
GIVEAWAYS
INCREMENT SERVICES
Magazine | Citations |
Clin Chim Acta | Interictal plasma pituitary adenylate cyclase-activating polypeptide levels are decreased in migraineurs but remain unchanged in patients with tension-type headache PubMed: 26296898 |
Neurol Sci | Significance of serum VIP and PACAP in multiple sclerosis: an exploratory case–control study 34698942 |
Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
RPB347Hu01 | Recombinant Pituitary Adenylate Cyclase Activating Peptide (PACAP) | Positive Control; Immunogen; SDS-PAGE; WB. |
CPB347Hu11 | BSA Conjugated Pituitary Adenylate Cyclase Activating Peptide (PACAP) | Immunogen; SDS-PAGE; WB. |
CPB347Hu12 | BSA Conjugated Pituitary Adenylate Cyclase Activating Peptide (PACAP) | Immunogen; SDS-PAGE; WB. |
PAB347Hu01 | Polyclonal Antibody to Pituitary Adenylate Cyclase Activating Peptide (PACAP) | WB,IHC |
MAB347Hu22 | Monoclonal Antibody to Pituitary Adenylate Cyclase Activating Peptide (PACAP) | WB; IHC; ICC; IP. |
CEB347Hu | ELISA Kit for Pituitary Adenylate Cyclase Activating Peptide (PACAP) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB347Hu | Multiplex Assay Kit for Pituitary Adenylate Cyclase Activating Peptide (PACAP) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |